4-phenylbutyric acid has been researched along with transforming growth factor beta in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Li, J; Liu, XQ; Tao, L; Wang, H; Wang, JQ; Xu, DX; Xu, YB; Zhang, C; Zhang, ZH | 1 |
Akuzum, B; Choi, SI; Jeong, JB; Kim, EK; Kim, TI; Lee, E; Maeng, YS | 1 |
2 other study(ies) available for 4-phenylbutyric acid and transforming growth factor beta
Article | Year |
---|---|
Phenylbutyric acid protects against carbon tetrachloride-induced hepatic fibrogenesis in mice.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum Stress; Hepatic Stellate Cells; Inflammation; Injections, Intraperitoneal; Liver Cirrhosis, Experimental; Male; Mice; Phenylbutyrates; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Unfolded Protein Response | 2013 |
4-Phenylbutyric acid reduces mutant-TGFBIp levels and ER stress through activation of ERAD pathway in corneal fibroblasts of granular corneal dystrophy type 2.
Topics: Apoptosis; Cells, Cultured; Cornea; Corneal Dystrophies, Hereditary; Dose-Response Relationship, Drug; Down-Regulation; Endoplasmic Reticulum Stress; Endoplasmic Reticulum-Associated Degradation; Extracellular Matrix Proteins; Fibroblasts; Humans; Mutation; Phenylbutyrates; Transforming Growth Factor beta | 2016 |